Skip to main content

Gould Robert J

In the past year, 3 open-market sale filings worth $489.3K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$489.3K
3 filings
Net
−$489.3K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Gould Robert J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

FULC Fulcrum Therapeutics, Inc.

Director8 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Feb 4, 2026 (view filing)Jan 233 daysGould Robert JDirectorSSale−15.0K$10.87−$163.1K−3.1%469.9K afterAmended
Feb 4, 2026 (view filing)Feb 22 daysGould Robert JDirectorSSale−15.0K$10.72−$160.8K−3.2%454.9K after
Nov 21, 2025 (view filing)Nov 192 daysGould Robert JDirectorSSale−15.0K$11.03−$165.4K−3.0%484.9K after
Jan 13, 2023 (view filing)Jan 13Same dayGould Robert JInterim President & CEOSSale−6.77K$15.00−$101.5K−1.3%499.9K after
Jun 8, 2022 (view filing)Jun 71 dayGould Robert JDirectorSSale−71.4K$8.09−$577.9K−12.4%506.6K after
Jun 6, 2022 (view filing)Jun 2-64 daysGould Robert JDirectorSSale−66.6K$8.00−$532.8K−11.6%506.6K after3 lots
Apr 11, 2022 (view filing)Apr 74 daysGould Robert JDirectorSSale−5.63K$24.02−$135.3K−1.1%506.6K after
Apr 5, 2022 (view filing)Apr 1-54 daysGould Robert JDirectorSSale−94.3K$24.16−$2.28M−15.7%506.6K after3 lots